Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
about
Huperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic ratsCerebral perfusion and aortic stiffness are independent predictors of white matter brain atrophy in type 1 diabetic patients assessed with magnetic resonance imaging.Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients.Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohortGLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests.Short and long term neuro-behavioral alterations in type 1 diabetes mellitus pediatric population.Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depressionBrain Activation and Psychomotor Speed in Middle-Aged Patients with Type 1 Diabetes: Relationships with Hyperglycemia and Brain Small Vessel Disease.Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study.Exercise therapy in type 2 diabetes.Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathyType 1 diabetes-associated cognitive decline: a meta-analysis and update of the current literature.Cerebrovascular complications of diabetes: focus on cognitive dysfunctionRegional Gray Matter Volumes as Related to Psychomotor Slowing in Adults with Type 1 Diabetes.Oxymatrine attenuates diabetes-associated cognitive deficits in rats.Cognition in Adults and Older Adults With Type 1 Diabetes: Chicken or Egg?Cognitive functions in children and adolescents with early-onset diabetes mellitus in Egypt.Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment.Enriched environment induces beneficial effects on memory deficits and microglial activation in the hippocampus of type 1 diabetic rats.Carvacrol attenuates diabetes-associated cognitive deficits in rats.Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus.Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats.Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy.Chrysin ameliorates diabetes-associated cognitive deficits in Wistar rats.Children and adolescents with type 1 diabetes and high HbA1c -- a neurodevelopmental perspective.Aortic stiffness is associated with white matter integrity in patients with type 1 diabetes.The total alkaloids from Franch improve cognitive deficits in type 2 diabetic ratsDiabetes cognitive impairments and the effect of traditional chinese herbs
P2860
Q33755620-7CB3680E-7A97-4C9E-B55D-69E763D0EFCDQ33788926-633B34DC-9E9A-4B3E-93BC-BFC36713B563Q33846616-5F2B9E21-2193-4D64-8BCF-9C2023A593A9Q33874731-916439FA-0F9A-494E-8399-5DAF142334A9Q34167980-6E0EED37-77C4-4C65-BE54-AE2FF892AB9CQ34389805-A7876E07-CBAE-43C9-83AC-DEC84A62D1EBQ35179229-8FCFDE2A-703A-4A1D-8CBF-3554F488B505Q36377600-1957CD1B-7454-46BA-9987-441A8B33FBABQ36655298-81D6C6A5-BB40-4D1E-A3D0-88ABCEB721DAQ37360461-8BBEC3F1-7504-4877-96BB-304530EE1726Q37412024-1F455E96-9E70-4F33-A73E-36586982AAD9Q37716664-91E8417E-776E-4AEC-9FDA-AE94F4089F97Q38231797-E88CBBDD-0F3E-41B7-BCB8-30B0D60F858AQ38955965-08F3EAAC-3C81-4D97-92FB-858EE669AF1DQ40375790-4636C3EF-0420-47BA-A2D1-48BC1B222882Q42589295-B83E65AF-03ED-4B4A-9426-14ABDDF27189Q42748386-3C7DD319-5204-4763-8318-A11C25E3360CQ46221510-90162502-1126-4E2B-A4FC-0740CA4D078EQ46945027-8F44B641-A610-4C32-8B7B-42B9D2ACE19AQ47822111-01905596-22A7-4AEF-8EE8-758966FA4D3EQ47955545-7082F2E3-A4E1-4FBF-9995-FCB99D5BCF82Q48250050-FBBCCB1D-D111-4E2A-8FE0-CA8E317B1CD4Q48917254-AF3172C1-CC20-4C4A-A62B-B2AEC79063BAQ49107139-67C0A186-809F-48A9-96B1-6BB18AF4FEAFQ50670098-F7B72E2A-FE87-4729-810C-3795F1C55C5AQ50767447-19AC5340-D239-498A-A6C7-181D52A6A23AQ53723951-3D5A0F69-CCF3-4775-BD8C-8B4231D2C77DQ58781641-D60E0113-778A-4D15-BD13-5E4759BA7AB8Q58922166-483A00FF-EA10-475A-BF32-696ADB9EB84D
P2860
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@en
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@nl
type
label
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@en
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@nl
prefLabel
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@en
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@nl
P921
P1476
Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
@en
P2093
Alette M Wessels
Robert J Heine
P356
10.1016/J.EJPHAR.2007.11.080
P407
P577
2008-03-04T00:00:00Z